Rhenium re-188
Star0
This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Explore a selection of our essential drug information below, or:
Identification
- Generic Name
- Rhenium re-188
- DrugBank Accession Number
- DB19267
- Background
Rhenium re-188 is under investigation in clinical trial NCT03458559 (Rhenium-188-hedp vs. Radium-223-chloride in Patients With Advanced Prostate Cancer Refractory to Hormonal Therapy).
- Type
- Small Molecule
- Groups
- Investigational
- Structure
- Weight
- Average: 187.9581
Monoisotopic: 187.958112287 - Chemical Formula
- Re
- Synonyms
- Rhenium-188
- Rhenium, isotope of mass 188
- External IDs
- 188RE
- Re 188
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Categories
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 229C124H5I
- CAS number
- 14378-26-8
- InChI Key
- WUAPFZMCVAUBPE-NJFSPNSNSA-N
- InChI
- InChI=1S/Re/i1+2
- IUPAC Name
- SMILES
- [188Re]
References
- General References
- Not Available
- External Links
- ChemSpider
- 146188
Clinical Trials
- Clinical Trials
Clinical Trial & Rare Diseases Add-on Data Package
Explore 4,000+ rare diseases, orphan drugs & condition pairs, clinical trial why stopped data, & more. Preview package Phase Status Purpose Conditions Count Start Date Why Stopped 100+ additional columns Unlock 175K+ rows when you subscribe.View sample data3 Unknown Status Treatment Prostate Cancer Metastatic to Bone 1 somestatus stop reason just information to hide 2 Recruiting Treatment Non-Resectable Hepatocellular Carcinoma 1 somestatus stop reason just information to hide 1 Completed Treatment Hepatocellular Carcinoma 1 somestatus stop reason just information to hide 1 Completed Treatment Metastatic Melanoma 1 somestatus stop reason just information to hide 0 Recruiting Treatment Breast Cancer / Radiotoxicity 1 somestatus stop reason just information to hide
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Not Available
- Chromatographic Properties
Collision Cross Sections (CCS)
Not Available
Drug created at July 12, 2024 16:45 / Updated at July 13, 2024 15:36